Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Transl Res ; 13(2): 515-531, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33594307

RESUMO

PURPOSE: Hepatitis B virus (HBV) infection is one main cause of hepatocellular carcinoma (HCC), but the mechanisms of pathogenesis still remain unclear. METHODS: We screened the 1351 differentially expressed genes related to HBV-induced HCC by bioinformatics analysis from databases and found that Plasminogen (PLG) may be a key gene in HBV-induced HCC progression. Then, we used a series of experiments in vivo and in vitro to explore the roles of PLG in HBV-HCC progression, such as qRT-PCR, western blot, ELISA, flow cytometry and TUNEL assay, subcutaneous xenografts and histopathological analysis to reveal the underlying mechanisms. RESULTS: PLG was over-expressed in HBV positive hepatocellular carcinoma tissues and cells. PLG silencing promoted HBV-HCC cell apoptosis in vitro and suppressed the growth of HBV-induced HCC xenografts in vivo both through inhibiting HBV replication. Then, GO and KEGG analysis of these differentially expressed genes revealed that the Hippo pathway was the key pathway involved in HBV-induced HCC, and SRC, a downstream target gene of PLG, was highly expressed in HBV-induced HCC and related to the Hippo pathway. Thus, we speculated that PLG promoted HBV-induced HCC progression through up-regulating and activating the expression of SRC and promoting Hippo signaling pathway function on HBV-HCC cell survival. CONCLUSION: Our study suggests PLG may be an activator of HBV-infected hepatocellular carcinoma development, as a novel prognostic biomarker and therapeutic target for HBV-HCC.

2.
Onco Targets Ther ; 13: 6073-6083, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32612368

RESUMO

BACKGROUND: Sustained proliferation and active metastasis are hallmarks of cancer, and they pose major challenges to the development of treatments and a cure for hepatocellular carcinoma (HCC). Thus, the mechanisms of proliferation, migration, and invasion of cancer cells need to be investigated. Many studies indicate that dysregulation of microRNA plays important roles in the progression of HCC, but the role of placenta-specific microRNA (miR-512-3p) in HCC has not been systematically investigated. PURPOSE: In the current study, the expression, biological function, and mechanisms of miR-512-3p involvement in HCC were investigated. METHODS: Real-time quantitative polymerase chain reaction assays were conducted to determine miR-512-3p levels in HCC tissues and cell lines. The StarBase V3.0 online platform was used to compare miR-512-3p levels in HCC tissues with TCGA data and to identify potential miR-512-3p target genes. Associations between miR-512-3p and clinicopathological characteristics were analyzed statistically. MTT, ethynyl deoxyuridine, and transwell assays were performed to assess cell viability, proliferation, migration, and invasion. The luciferase reporter gene assay was used to verify target genes. Recuse assays were performed to confirm whether large tumor suppressor kinase 2 (LATS2) participated in the regulatory effects of miR-512-3p on HCC cell proliferation and motility, and whether miR-512-3p mediated the tumor-promoting effects of hypoxia. RESULTS: miR-512-3p was upregulated in HCC and it was associated with worse survival and unfavorable clinicopathological characteristics. Functional assays indicated that miR-512-3p contributed to HCC cell proliferation, migration, and invasion. Mechanistically, LATS2-a downstream target of miR-512-3p-mediated the tumor-promoting effects of miR-512-3p in HCC. Hypoxia could elevate miR-512-3p levels in HCC cells, and miR-512-3p partially mediated the tumor-promoting effects of hypoxia. CONCLUSION: Hypoxia-induced miR-512-3p contributes to HCC cell proliferation, migration, and invasion by targeting LATS2 and inhibiting the Hippo/yes-associated protein 1 pathways.

3.
Neurobiol Learn Mem ; 139: 22-27, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27993649

RESUMO

Recent research has shown that reinforcement can facilitate visual perceptual learning (VPL), but no study has examined the relations between individual differences in reinforcement sensitivity and VPL. This study tested the hypothesis that when monetary incentive was involved, the personality traits of harm avoidance and reward dependence (HA and RD, two measures of reinforcement sensitivity) would be linked to VPL performance. We trained two groups of subjects with a visual motion direction discrimination task for six days. The experimental group received monetary incentive feedback, whereas the control group received non-monetary feedback. As expected, the score of HA was negatively correlated with VPL for the experimental group, but not for the control group. RD was not a significant predictor. These results were discussed in terms of the role of non-perceptual factors such as reinforcement, personality, higher cognition, and motivation in VPL.


Assuntos
Aprendizagem por Discriminação/fisiologia , Percepção de Movimento/fisiologia , Motivação , Personalidade , Percepção Visual/fisiologia , Adulto , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Reforço Psicológico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...